July 23, 2016
Recommended Topic Related To:

Tudorza Pressair

"On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need f"...

A A A

Tudorza Pressair

Overdosage
Contraindications

OVERDOSE

Human Experience

No case of overdose has been reported in clinical studies with TUDORZA PRESSAIR. There were no systemic anticholinergic or other adverse effects following a single inhaled dose of up to 6,000 mcg aclidinium bromide (7.5 times the RHDD) in 16 healthy volunteers.

CONTRAINDICATIONS

The use of TUDORZA PRESSAIR is contraindicated in the following conditions:

  • Severe hypersensitivity to milk proteins [see WARNINGS AND PRECAUTIONS]
  • Hypersensitivity to aclidinium bromide or any of the excipients [see WARNINGS AND PRECAUTIONS]
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 3/29/2016

Overdosage
Contraindications

Additional Tudorza Pressair Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.